Home Translational Research Human Clinical Research
Human Clinical Research
The overall objective of the Gallo Center’s Human Clinical Research group is to accelerate the exploitation of preclinical research findings to improve understanding of disease mechanisms in humans, and to confirm clinical value or potential molecular targets for new therapeutics.


clinical.JPG


Howard Fields, MD PhD, Director of Human Translational Research
Jennifer Mitchell, PhD, Clinical Project Director
Andrew Kayser, MD PhD, Principal Investigator

Anna Woods, NP, Nurse Practitioner
Amber McElfresh, PharmD, Pharmacist
Kaleas Johnson, Project Administrator

Candice Teague, Staff Research Associate
Allison Coker, Staff Research Associate
Daicia Allen, Staff Research Associate



The Human Clinical Research group supports projects in two key areas:

  1. Human neurobiology of alcoholism and addiction, including behavioral testing and functional imaging, which will help us to better define human phenotypes.
  2. Proof of concept clinical trials using existing drugs to test molecular targets that have been identified and/or validated in animal studies.

    Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake

    Data Analysis Phase

     

    Human Functional Imaging of CNS Opioids in Alcohol Reward

    Data Analysis Phase

     

    Varenicline Treatment of Hazardous Drinking in Cigarette Smokers

    Now Recruiting - click here

    A Randomized, Double-Blind Study of Neural Circuit Responses to COMT Inhibitors

    Now Recruiting - click here




    For additional information on any of our studies, please call (510)985-3910.